Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03336437 · ClinicalTrials.gov registry record · Phase 4
Estrogen and the Urogenital Microbiome in GSM
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT03336437 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 40 participants.
The verdict
NCT03336437, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a study of how local estrogen treatment affects the microbiome of the vagina and bladder in postmenopausal women experiencing symptoms as part of "Genitourinary Syndrome of Menopause." The goal is to understand more about the underlying microbial changes occurring in menopause and whether these are reversible with estrogen.
Interventions
- DRUG Estradiol vaginal ring
- OTHER Placebo vaginal ring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2019-08-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03336437
The ClinicalTrials.gov registry entry for NCT03336437 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Estradiol vaginal ring is the first listed.
NCT03336437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03336437 about?
NCT03336437 is a clinical study titled "Estrogen and the Urogenital Microbiome in GSM". This is a study of how local estrogen treatment affects the microbiome of the vagina and bladder in postmenopausal women experiencing symptoms as part of "Genitourinary Syndrome of Menopause." The goal is to understand more about the underlying microbial changes occurring in menopause and whether th...
What is the current status of trial NCT03336437?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2018-02-01. Estimated completion is 2019-08-23.
What interventions are being tested in trial NCT03336437?
The interventions under investigation include: Estradiol vaginal ring (DRUG), Placebo vaginal ring (OTHER).
Who is sponsoring clinical trial NCT03336437?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.